Generic Drug Makers Say ‘No’ To Health Reform Tab
Makers of generic drugs say it’s unfair to make them pay $460 million to help fund health care overhaul legislation. They warn consumer prices could rise if Congress approves the 10 years of increased Medicaid discounts included in the bill passed by the Senate Finance Committee Tuesday.